Accession Number: | 0001689813-19-000110 |
Date: | 2019-11-25 |
Issuer: | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. (BHVN) |
Original Submission Date: |
CONWAY CHARLES
C/O BIOHAVEN PHARMACEUTICALS, INC., 215
CHURCH STREET
NEW HAVEN, CT 06510
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 57.4 | 2019-11-25 | deemed execution date | A | 25,000 (a) | 2029-11-24 | common shares 25,000 | $57.40 | 25,000 | direct | ||
RESTRICTED SHARE UNIT AWARD | 0.0 | 2019-11-25 | deemed execution date | A | 12,000 (a) | 2022-11-24 | common shares 12,000 | $0.00 | 12,000 | direct |
ID | footnote |
---|---|
f1 | the shares underlying this option vest in four equal installments on november 25, 2019, 2020, 2021 and 2022, subject to the optionholder's continuous service with the issuer at each vesting date. |
f2 | each restricted share unit represents the contingent right to receive one common share of biohaven pharmaceutical holding co ltd. |
f3 | the reporting person was granted 12,000 restricted share units on november 25, 2019, vesting in four equal installments on november 25, 2019, 2020, 2021 and 2022 subject to the reporting person's continued service with the issuer at each vesting date. |